The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(3,4-Dihydroxybenzylidenyl)-3-(3,4-dihydroxyphenyl)-4-hydroxypentanedioic acid ID: ALA3112597
PubChem CID: 57620293
Max Phase: Preclinical
Molecular Formula: C18H16O9
Molecular Weight: 376.32
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(O)/C(=C\c1ccc(O)c(O)c1)C(c1ccc(O)c(O)c1)C(O)C(=O)O
Standard InChI: InChI=1S/C18H16O9/c19-11-3-1-8(6-13(11)21)5-10(17(24)25)15(16(23)18(26)27)9-2-4-12(20)14(22)7-9/h1-7,15-16,19-23H,(H,24,25)(H,26,27)/b10-5-
Standard InChI Key: GRVCQHNOZLCUEA-YHYXMXQVSA-N
Molfile:
RDKit 2D
27 28 0 0 0 0 0 0 0 0999 V2000
6.6651 -4.0083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.6640 -4.8356 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3788 -5.2485 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0952 -4.8351 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0924 -4.0047 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3770 -3.5955 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.9492 -5.2475 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.9506 -3.5959 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8104 -5.2465 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8116 -6.0715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5268 -6.4829 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.0979 -6.4851 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.3813 -6.0746 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.0976 -7.3110 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
9.5281 -7.3079 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2406 -6.0693 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9557 -6.4807 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2393 -5.2443 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
10.9581 -7.3064 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
11.6706 -6.0678 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.8156 -7.7186 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.8166 -8.5428 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5322 -8.9551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2485 -8.5370 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.2439 -7.7141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
9.5346 -9.7800 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.1026 -8.9561 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
2 7 1 0
1 8 1 0
4 9 1 0
9 10 2 0
10 11 1 0
10 12 1 0
12 13 1 0
12 14 2 0
11 15 1 0
11 16 1 0
16 17 1 0
16 18 1 0
17 19 1 0
17 20 2 0
15 21 2 0
21 22 1 0
22 23 2 0
23 24 1 0
24 25 2 0
25 15 1 0
23 26 1 0
22 27 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 376.32Molecular Weight (Monoisotopic): 376.0794AlogP: 1.21#Rotatable Bonds: 6Polar Surface Area: 175.75Molecular Species: ACIDHBA: 7HBD: 7#RO5 Violations: 1HBA (Lipinski): 9HBD (Lipinski): 7#RO5 Violations (Lipinski): 1CX Acidic pKa: 2.54CX Basic pKa: ┄CX LogP: 1.51CX LogD: -5.45Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.29Np Likeness Score: 0.88
References 1. Chen YS, Yu HM, Shie JJ, Cheng TJ, Wu CY, Fang JM, Wong CH.. (2014) Chemical constituents of Plectranthus amboinicus and the synthetic analogs possessing anti-inflammatory activity., 22 (5): [PMID:24491635 ] [10.1016/j.bmc.2014.01.009 ]